Literature DB >> 26976498

The impact of aerobic exercise training on cardiopulmonary functioning in individuals with schizophrenia.

Hilary F Armstrong1, Matthew N Bartels2, Orest Paslavski3, Darnell Cain3, Hannah A Shoval3, Jacob S Ballon4, Samira Khan5, Richard P Sloan6, David Kimhy6.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26976498     DOI： 10.1016/j.schres.2016.03.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  10 in total

1.  Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function.

Authors:  Sophia Kogan; Luz H Ospina; David Kimhy
Journal:  Brain Behav Immun       Date:  2018-09-12       Impact factor: 7.217

2.  Cardiorespiratory benefits of group exercise among adults with serious mental illness.

Authors:  Gerald J Jerome; Deborah Rohm Young; Arlene T Dalcin; Nae-Yuh Wang; Joseph Gennusa; Stacy Goldsholl; Lawrence J Appel; Gail L Daumit
Journal:  Psychiatry Res       Date:  2017-06-10       Impact factor: 3.222

3.  Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in Individuals with Schizophrenia.

Authors:  Luz H Ospina; Melanie Wall; Lars F Jarskog; Jacob S Ballon; Joseph McEvoy; Matthew N Bartels; Richard Buchsbaum; Richard P Sloan; T Scott Stroup; David Kimhy
Journal:  J Psychiatr Brain Sci       Date:  2019-12-30

4.  A web-based adapted physical activity program (e-APA) versus health education program (e-HE) in patients with schizophrenia and healthy volunteers: study protocol for a randomized controlled trial (PEPSY V@Si).

Authors:  Maxime Tréhout; Elise Leroux; Lucile Bigot; Solenne Jego; Pascal Leconte; Emmanuel Reboursière; Rémy Morello; Pierre-Alexandre Chapon; Aline Herbinet; Gaëlle Quarck; Sonia Dollfus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-26       Impact factor: 5.270

5.  Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits.

Authors:  Julia Vakhrusheva; Brielle Marino; T Scott Stroup; David Kimhy
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-04

6.  Psychosis risk individuals show poor fitness and discrepancies with objective and subjective measures.

Authors:  David Kimhy; Vijay A Mittal; Katherine S F Damme; Richard P Sloan; Matthew N Bartels; Alara Ozsan; Luz H Ospina
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

Review 7.  Aerobic Exercise Improves Cognitive Functioning in People With Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Joseph Firth; Brendon Stubbs; Simon Rosenbaum; Davy Vancampfort; Berend Malchow; Felipe Schuch; Rebecca Elliott; Keith H Nuechterlein; Alison R Yung
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

Review 8.  Considering the Microbiome in Stress-Related and Neurodevelopmental Trajectories to Schizophrenia.

Authors:  Kevin W Hoffman; Jakleen J Lee; Cheryl M Corcoran; David Kimhy; Thorsten M Kranz; Dolores Malaspina
Journal:  Front Psychiatry       Date:  2020-07-03       Impact factor: 4.157

9.  Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia-A Systematic Review.

Authors:  Ewa Tumiel; Adam Wichniak; Marek Jarema; Michał Lew-Starowicz
Journal:  Front Psychiatry       Date:  2019-08-16       Impact factor: 4.157

10.  Suicide Reduction in Schizophrenia via Exercise (SUnRISE): study protocol for a multi-site, single-blind, randomized clinical trial of aerobic exercise for suicide risk reduction in individuals with schizophrenia.

Authors:  Katie Beck-Felts; Marianne Goodman; Luz H Ospina; Melanie Wall; Joseph McEvoy; Lars F Jarskog; Jacob S Ballon; Matthew N Bartels; Richard Buchsbaum; Richard P Sloan; T Scott Stroup; David Kimhy
Journal:  Trials       Date:  2020-10-21       Impact factor: 2.279
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.